PEREGRINE PHARMACEUTICALS INC 4
4 · PEREGRINE PHARMACEUTICALS INC · Filed Apr 28, 2017
Insider Transaction Report
Form 4
KING STEVEN W
DirectorPresident & CEO
Transactions
- Other
Common Stock
2017-04-28$0.27/sh+19,941$5,408→ 232,730 total
Footnotes (1)
- [F1]Shares acquired under the issuer's employee stock purchase plan on April 28, 2017